The weekly litigation news digest is live. Subscribe now

IP Verse

Compositions For The Treatment Of Inflammation Of The Gastrointestinal Tract - EP2214677

The patent EP2214677 was granted to Meritage Pharma on Aug 30, 2017. The application was filed on Nov 12, 2008 under application number EP08848917A. The patent is currently recorded with a legal status of "Revoked".

EP2214677

MERITAGE PHARMA
Application Number
EP08848917A
Filing Date
Nov 12, 2008
Status
Revoked
Dec 13, 2019
Publication Date
Aug 30, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
DR FALK PHARMAMay 22, 2018KELLER -

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTUS2001049366
INTERNATIONAL-SEARCH-REPORTUS2007111978
INTERNATIONAL-SEARCH-REPORTUS6387383
INTERNATIONAL-SEARCH-REPORTWO2005074930
OPPOSITIONUS2007111978
OPPOSITIONWO2004082590
OPPOSITIONWO9939699
SEARCHUS2007111978
SEARCHWO0141748
SEARCHWO2006103702

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents